Department of Anesthesiology, Section of Neuroanesthesia.
Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
J Neurosurg Anesthesiol. 2023 Apr 1;35(2):238-242. doi: 10.1097/ANA.0000000000000822. Epub 2021 Dec 2.
The speculation that cerebral tissue oxygen saturation (SctO 2 ) measured using tissue near-infrared spectroscopy reflects the balance between cerebral metabolic rate of oxygen and cerebral oxygen delivery has not been validated. Our objective was to correlate SctO 2 with cerebral oxygen extraction fraction (OEF) measured using positron emission tomography; OEF is the ratio between cerebral metabolic rate of oxygen and cerebral oxygen delivery and reflects the balance between these 2 variables.
This cohort study was based on data collected in a previously published trial assessing phenylephrine versus ephedrine treatment in anesthetized patients undergoing brain tumor surgery. The variables of interest were measured twice over the healthy hemisphere before surgery: the first measurement performed after anesthesia induction and the second measurement performed after induction of a ∼20% increase in blood pressure using either phenylephrine or ephedrine.
Data from 24 patients were analyzed. The overall vasopressor-induced relative changes in SctO 2 (ΔSctO 2 ) and OEF (ΔOEF) were 3.16% [interquartile range, -0.73% to 6.04%] and -12.5% [interquartile range, -24.0% to -6.19%], respectively. ΔSctO 2 negatively correlated with ΔOEF after phenylephrine treatment (Spearman rank correlation coefficient [ rs ]=-0.76; P =0.007), ephedrine treatment ( rs =-0.76; P =0.006), and any treatment ( rs =-0.79; P <0.001). ΔSctO 2 significantly associated with ΔOEF based on multivariable analysis with ΔOEF, relative changes in mean arterial pressure, arterial blood oxygen tension, and the bispectral index as covariates ( P =0.036).
The negative correlation between changes in SctO 2 and OEF suggests that SctO 2 may reflect the cerebral metabolic demand-supply balance during vasopressor treatment. The generalizability of our findings in other clinical scenarios remains to be determined.
使用组织近红外光谱测量脑组织氧饱和度(SctO2)来推测其反映了脑氧代谢率与脑氧输送之间的平衡,但这一推测尚未得到验证。我们的目的是将 SctO2 与使用正电子发射断层扫描测量的脑氧提取分数(OEF)进行相关分析;OEF 是脑氧代谢率与脑氧输送之间的比值,反映了这两个变量之间的平衡。
这项队列研究基于先前发表的一项评估麻醉患者脑肿瘤手术中使用苯肾上腺素与麻黄碱治疗的试验中收集的数据。在手术前对健康半球进行了两次有兴趣的变量测量:第一次测量是在麻醉诱导后进行,第二次测量是在使用苯肾上腺素或麻黄碱诱导血压升高约 20%后进行。
分析了 24 例患者的数据。SctO2(ΔSctO2)和 OEF(ΔOEF)的总体血管加压剂诱导相对变化分别为 3.16%[四分位距,-0.73%至 6.04%]和-12.5%[四分位距,-24.0%至-6.19%]。苯肾上腺素治疗后,ΔSctO2 与 ΔOEF 呈负相关(Spearman 秩相关系数[rs]=-0.76;P=0.007),麻黄碱治疗后(rs=-0.76;P=0.006),以及任何治疗后(rs=-0.79;P<0.001)。基于多变量分析,ΔSctO2 与 ΔOEF 显著相关,将相对变化的平均动脉压、动脉血氧分压和双频谱指数作为协变量(P=0.036)。
SctO2 与 OEF 的变化呈负相关,提示 SctO2 可能反映了血管加压剂治疗期间脑代谢需求-供应的平衡。我们的发现在其他临床情况下的普遍性仍有待确定。